JOURNAL ARTICLE

Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment

Keywords:
Dasatinib GiST Medicine Nilotinib Imatinib Internal medicine PDGFRA Oncology Progression-free survival Imatinib mesylate Stromal tumor Tyrosine-kinase inhibitor Gastroenterology Stromal cell Chemotherapy Cancer

Metrics

5
Cited By
0.41
FWCI (Field Weighted Citation Impact)
22
Refs
0.61
Citation Normalized Percentile
Is in top 1%
Is in top 10%

Citation History

Topics

Gastrointestinal Tumor Research and Treatment
Health Sciences →  Medicine →  Gastroenterology
Gastric Cancer Management and Outcomes
Health Sciences →  Medicine →  Pulmonary and Respiratory Medicine
Neurofibromatosis and Schwannoma Cases
Health Sciences →  Medicine →  Neurology

Related Documents

© 2026 ScienceGate Book Chapters — All rights reserved.